Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2007 1
2009 1
2012 2
2016 1
2017 1
2019 3
2020 2
2021 1
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.
Chen B, Zhang Y, Dai S, Zhou P, Luo W, Wang Z, Chen X, Cheng P, Zheng G, Ren J, Yang X, Li W. Chen B, et al. Signal Transduct Target Ther. 2021 Jan 8;6(1):6. doi: 10.1038/s41392-020-00382-6. Signal Transduct Target Ther. 2021. PMID: 33414372 Free PMC article.
Primary pulmonary lymphoepithelioma-like carcinoma (pLELC) is a rare non-small cell lung cancer (NSCLC) subtype. ...Multiomics genomic analyses, including whole-genome sequencing (WGS), RNA whole-transcriptome sequencing (RNA-seq), and Epstein-Barr vir …
Primary pulmonary lymphoepithelioma-like carcinoma (pLELC) is a rare non-small cell lung cancer (NSCLC) subtype. …
Treatment of Lung Carcinosarcoma and Other Rare Histologic Subtypes of Non-small Cell Lung Cancer.
Yang H, Lin Y, Liang Y. Yang H, et al. Curr Treat Options Oncol. 2017 Aug 10;18(9):54. doi: 10.1007/s11864-017-0494-9. Curr Treat Options Oncol. 2017. PMID: 28795312 Review.
Lung carcinosarcoma (PCS) and other histological subtypes of non-small cell lung cancer, such as primary pulmonary lymphoma (PPL), pulmonary carcinoid (PC), and primary pulmonary lymphoepithelioma-like carcinoma (LELC), are rare. ...Some patient …
Lung carcinosarcoma (PCS) and other histological subtypes of non-small cell lung cancer, such as primary pulmonary lymphoma (P …
A Clinical Analysis and Literature Review of Six Cases with Primary Pulmonary Lymphoepithelioma-Like Carcinoma.
Ye L, Luo D, Li H, Zheng H, He S, Lin L, Fang Y, Ye J, Chen C. Ye L, et al. Comput Math Methods Med. 2022 Apr 29;2022:1086697. doi: 10.1155/2022/1086697. eCollection 2022. Comput Math Methods Med. 2022. PMID: 35529269 Free PMC article. Retracted. Review.
METHODS: The clinical data of six patients with primary pulmonary lymphoepithelioma-like carcinoma treated in Zhejiang Taizhou Hospital of Taizhou Enze Medical Center (Group) from May 2014 to December 2018 were summarized and analyzed. Combined with the relev …
METHODS: The clinical data of six patients with primary pulmonary lymphoepithelioma-like carcinoma treated in Zhejiang …
Analysis of clinical features, treatment, and prognosis of primary Xlymphoepithelioma-like carcinoma of the lung.
Hu HY, Long L, Dai SA, Yan GQ, Huang Y, He J. Hu HY, et al. Eur Rev Med Pharmacol Sci. 2022 Dec;26(24):9416-9425. doi: 10.26355/eurrev_202212_30693. Eur Rev Med Pharmacol Sci. 2022. PMID: 36591850 Free article.
OBJECTIVE: Primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) is a rare lung malignancy occurring most frequently in young non-smokers from Southeast Asia. ...CONCLUSIONS: Primary pulmonary lymphoepithelioma-like carcinoma …
OBJECTIVE: Primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) is a rare lung malignancy occurring most …
Anti-PD-1 antibodies, a novel treatment option for advanced chemoresistant pulmonary lymphoepithelioma carcinoma.
Zhou N, Tang H, Yu S, Lin Y, Wang Y, Wang Y. Zhou N, et al. Front Immunol. 2022 Dec 6;13:1001414. doi: 10.3389/fimmu.2022.1001414. eCollection 2022. Front Immunol. 2022. PMID: 36561745 Free PMC article.
BACKGROUND: Pulmonary lymphoepithelioma-like carcinoma (LELC) exhibits a unique immune microenvironment, including high PD-L1 expression and abundant infiltrating-immune cells. ...
BACKGROUND: Pulmonary lymphoepithelioma-like carcinoma (LELC) exhibits a unique immune microenvironment, including high …
About thymic carcinomas: challenges in diagnosis and management.
Mlika M, Boudaya S, Braham E, Chermiti F, Sayi A, Marghli A, El Mezni F. Mlika M, et al. Asian Cardiovasc Thorac Ann. 2016 May;24(4):350-4. doi: 10.1177/0218492316640129. Epub 2016 Mar 21. Asian Cardiovasc Thorac Ann. 2016. PMID: 27002097
BACKGROUND: Thymic carcinomas are rare tumors with a challenging diagnosis. Our aim was to report our 17-year experience of these tumors and to highlight the challenges encountered and the main differential diagnoses ruled out. ...RESULTS: The diagnosis was made on surgica …
BACKGROUND: Thymic carcinomas are rare tumors with a challenging diagnosis. Our aim was to report our 17-year experience of these tum …
Clinical features and treatment outcome of lymphoepithelioma-like carcinoma from multiple primary sites: a population-based, multicentre, real-world study.
Chen M, Chen Y, Fang X, Wang Z, Pu X, Liang C, Guo H, Li Q, Pan F, Hong H, Huang H, Li J, Lin T. Chen M, et al. BMC Pulm Med. 2022 Sep 22;22(1):360. doi: 10.1186/s12890-022-02097-6. BMC Pulm Med. 2022. PMID: 36138362 Free PMC article.
BACKGROUND: Lymphoepithelioma-like carcinoma (LELC) is a rare and unique subtype of cancer that histologically resembles undifferentiated nasopharyngeal carcinoma (NPC). ...Randomized controlled studies are necessary to further define the standard of …
BACKGROUND: Lymphoepithelioma-like carcinoma (LELC) is a rare and unique subtype of cancer that histologically resemble …
Primary pulmonary lymphoepithelioma-like carcinoma: a rare type of lung cancer with a favorable outcome in comparison to squamous carcinoma.
Chen B, Chen X, Zhou P, Yang L, Ren J, Yang X, Li W. Chen B, et al. Respir Res. 2019 Nov 21;20(1):262. doi: 10.1186/s12931-019-1236-2. Respir Res. 2019. PMID: 31752892 Free PMC article.
BACKGROUND: Primary pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare tumor and often misdiagnosed as squamous carcinoma. In the current study, clinical characteristics and outcome of primary pulmonary LELC were systematically compared with p …
BACKGROUND: Primary pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare tumor and often misdiagnosed as squamou …
Capecitabine as salvage treatment for lymphoepithelioma-like carcinoma of lung.
Ho JC, Lam DC, Wong MK, Lam B, Ip MS, Lam WK. Ho JC, et al. J Thorac Oncol. 2009 Sep;4(9):1174-7. doi: 10.1097/JTO.0b013e3181b28f15. J Thorac Oncol. 2009. PMID: 19704339 Free article.
Lymphoepithelioma-like carcinoma (LELC) of lung has previously demonstrated good clinical response to 5-fluorouracil containing chemotherapy regimen, similar to the observation in undifferentiated nasopharyngeal carcinoma. Capecitabine, which is …
Lymphoepithelioma-like carcinoma (LELC) of lung has previously demonstrated good clinical response to 5-fluorour …
Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up.
Liang Y, Wang L, Zhu Y, Lin Y, Liu H, Rao H, Xu G, Rong T. Liang Y, et al. Cancer. 2012 Oct 1;118(19):4748-58. doi: 10.1002/cncr.27452. Epub 2012 Feb 22. Cancer. 2012. PMID: 22359203 Free article.
BACKGROUND: Pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare kind of cancer. METHODS: In this study, the authors evaluated 52 patients with pulmonary LELC who had long-term follow-up. ...CONCLUSIONS: Pulmonary LELC obviously is a distinct entity of …
BACKGROUND: Pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare kind of cancer. METHODS: In this study, the aut …
17 results